Eterna Therapeutics Inc (ERNA) — Cash Flow Reinvestment Rate
Eterna Therapeutics Inc (ERNA) has a Cash Flow Reinvestment Rate of 0.00x as of September 2019, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $88.00 Million. Check Eterna Therapeutics Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Eterna Therapeutics Inc Cash Flow Reinvestment Rate (2009–2019)
Historical reinvestment intensity for Eterna Therapeutics Inc across 9 annual periods. Explore ERNA strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Eterna Therapeutics Inc (2009–2019)
Year-by-year capital reinvestment analysis for Eterna Therapeutics Inc. For live market cap and broader valuation context, see Eterna Therapeutics Inc market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.40x | $1.09 Million | $2.74 Million | $1.09 Million | ▼ -66.2% |
| 2018 | 1.18x | $1.61 Million | $1.36 Million | $1.61 Million | ▼ -55.3% |
| 2017 | 2.64x | $1.45 Million | $549.00K | $1.45 Million | ▼ -92.8% |
| 2016 | 36.52x | $840.00K | $23.00K | $840.00K | ▲ +6233.0% |
| 2013 | 0.58x | $861.00K | $1.49 Million | $861.00K | ▲ +1.4% |
| 2012 | 0.57x | $1.23 Million | $2.16 Million | $1.23 Million | ▼ -79.5% |
| 2011 | 2.78x | $1.59 Million | $574.00K | $1.59 Million | ▲ +494.2% |
| 2010 | 0.47x | $1.32 Million | $2.83 Million | $1.32 Million | ▼ -38.8% |
| 2009 | 0.76x | $1.91 Million | $2.50 Million | $1.91 Million | — |